Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Montebello, California Clinical Trials

A listing of Montebello, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (13) clinical trials

Connected Catheter- Evaluation Study

Spinal Singularity had developed Connected Catheter System to address several drawbacks of current standard-of-care urinary catheters. The Connected Catheter is fully internal, urethral indwelling urinary prosthesis designed for improved bladder management in males with urinary retention disorders requiring catheterization. Each subject will use the Connected Catheter for up to 35-40 ...

Phase N/A

5.26 miles

Learn More »

Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

PRIMARY OBJECTIVES: I. To compare overall survival between patients previously treated with platinum-based chemotherapy and immunotherapy for stage IV or recurrent non-small cell lung cancer randomized to ramucirumab and MK-3475 (pembrolizumab) versus standard of care (SoC). SECONDARY OBJECTIVES: I. To compare response rates between the arms, including complete response (CR) ...

Phase

5.63 miles

Learn More »

An Efficacy Study Comparing Brigatinib Versus Alectinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Participants Who Have Progressed on Crizotinib

The drug being tested in this study is called brigatinib. Brigatinib has been demonstrated to benefit people with ALK-positive NSCLC. The comparator drug is called alectinib. Alectinib has been demonstrated to benefit people with ALK-positive NSCLC. Both drugs belong to a class of drugs called ALK inhibitors. Both drugs are ...

Phase

5.63 miles

Learn More »

Movement and Fitness Trackers in Determining Performance Status

PRIMARY OBJECTIVES: I. To determine if in-office movement trackers identify those patients who are at highest risk for serious adverse events (SAEs) on early and developmental therapeutics (EDT) cancer trials. SECONDARY OBJECTIVES: Secondary objectives are related to outpatient activity trackers. I. To determine the association between the occurrence of SAEs ...

Phase N/A

5.86 miles

Learn More »

Effects of Nicotine in Tobacco Smokers

This study will examine mechanisms linking Obsessive-Compulsive Disorder symptomatology to tobacco dependence.

Phase

5.86 miles

Learn More »

AO-176 in Multiple Solid Tumor Malignancies

This study will examine AO-176 monotherapy in patients with select advanced solid tumors for which standard therapy proven to provide clinical benefit does not exist or is no longer effective. The study utilizes a classic 3+3 design, with enrollment of 3 patients per cohort and expansion of the cohort in ...

Phase

5.86 miles

Learn More »

Papillary Balloon Dilation Versus Intraductal Lithotripsy

The study will be a prospective single blind randomized comparative trial. All patients presenting with choledocholithiasis will be considered for the study. If their ultrasound, computed tomography, or magnetic resonance imaging demonstrates a large stone (>1cm) and they do not fulfill the exclusion criterion they will be eligible for the ...

Phase N/A

5.86 miles

Learn More »

A Study of AKR-001 in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

This is a multi-center evaluation of AKR-001 in a randomized, double-blind, placebo-controlled study administered for 16 weeks in subjects with biopsy proven F1 - F3 NASH.

Phase

6.47 miles

Learn More »

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

The goal for this study is to evaluate the efficacy and safety of tirzepatide versus placebo in participants with type 2 diabetes not under control with diet and exercise alone. The study will last approximately 47 weeks and may include about 15 visits.

Phase

6.47 miles

Learn More »

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition

Patients with chronic kidney disease, who have evidence of systemic inflammation with increased cardiovascular risk, will be enrolled into this trial. The purpose of this trial is to determine a dose to select for a potential cardiovascular outcome trial with Ziltivekimab. Doses to be tested will be 7.5 mg, 15 ...

Phase

8.12 miles

Learn More »